AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
ABT vs AMGN Fundamental Comparison
| Metric | ABT | AMGN |
|---|---|---|
| Revenue | $44.3B | $36.8B |
| Net Income | $6.5B | $7.7B |
| Net Margin | 14.7% | 21.0% |
| ROE | 12.5% | 89.1% |
| ROA | 7.5% | 8.5% |
| Current Ratio | 1.58x | 1.14x |
| Debt/Equity | 0.25x | 6.31x |
| EPS | $3.72 | $14.23 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs AMGN: Frequently Asked Questions
Is ABT or AMGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. ABT is rated BUY (77% confidence) while AMGN is rated BUY (84% confidence). This is not investment advice.
How does ABT compare to AMGN fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs AMGEN INC's 89.1%. Net margins are 14.7% vs 21.0% respectively.
Which stock pays higher dividends, ABT or AMGN?
ABT has a dividend yield of N/A or no dividend while AMGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or AMGN for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while AMGN has BUY rating with 84% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs AMGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs AMGN, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.